Chemoinformaics analysis of 7-HYDROXY-4-(3-HYDROXY-4-METHOXYPHENYL)-5-METHOXYCHROMEN-2-ONE
Molecular Weight | 314.293 | nRot | 3 |
Heavy Atom Molecular Weight | 300.181 | nRig | 18 |
Exact Molecular Weight | 314.079 | nRing | 3 |
Solubility: LogS | -3.585 | nHRing | 1 |
Solubility: LogP | 2.587 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 42.5371 |
nHD | 2 | BPOL | 20.1209 |
QED | 0.723 |
Synth | 2.306 |
Natural Product Likeliness | 0.995 |
NR-PPAR-gamma | 0.936 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0.988 |
HIA | 0.018 |
CACO-2 | -4.809 |
MDCK | 0.0000166 |
BBB | 0.03 |
PPB | 0.936332 |
VDSS | 0.749 |
FU | 0.092092 |
CYP1A2-inh | 0.966 |
CYP1A2-sub | 0.958 |
CYP2c19-inh | 0.663 |
CYP2c19-sub | 0.061 |
CYP2c9-inh | 0.559 |
CYP2c9-sub | 0.925 |
CYP2d6-inh | 0.778 |
CYP2d6-sub | 0.918 |
CYP3a4-inh | 0.831 |
CYP3a4-sub | 0.24 |
CL | 11.93 |
T12 | 0.863 |
hERG | 0.094 |
Ames | 0.307 |
ROA | 0.038 |
SkinSen | 0.594 |
Carcinogencity | 0.042 |
EI | 0.917 |
Respiratory | 0.347 |
NR-Aromatase | 0.718 |
Antiviral | Yes |
Prediction | 0.787448 |